Multiple pathogenic factor-induced complications of cirrhosis in rats: a new model of hepatopulmonary syndrome with intestinal endotoxemia.
OBJECTIVE
To develop and characterize a practical model of Hepatopulmonary syndrome (HPS) in rats.


METHODS
The experimental animals were randomized into five feeding groups: (1) control (fed standard diet), (2) control plus intraperitoneal injection with lipopolysaccharide (LPS), (3) cirrhosis (fed a diet of maize flour, lard, cholesterol, and alcohol plus subcutaneously injection with carbon tetrachloride (CCl(4)) oil solution), (4) cirrhosis plus LPS, and (5) cirrhosis plus glycine and LPS. The blood, liver and lung tissues of rats were sampled for analysis and characterization. Technetium 99m-labeled macroaggregated albumin (Tc99m-MAA) was used to test the dilatation of pulmonary microvasculature.


RESULTS
Typical cirrhosis and subsequent hepato-pulmonary syndrome was observed in the cirrhosis groups after an 8 wk feeding period. In rats with cirrhosis, there were a decreased PaO(2) and PaCO(2) in arterial blood, markedly decreased arterial O(2) content, a significantly increased alveolar to arterial oxygen gradient, an increased number of bacterial translocated within mesenteric lymph node, a significant higher level of LPS and tumor necrosis factor-alpha (TNF-alpha) in plasma, and a significant greater ratio of Tc99m-MAA brain-over-lung radioactivity. After LPS administration in rats with cirrhosis, various pathological parameters got worse and pulmonary edema formed. The predisposition of glycine antagonized the effects of LPS and significantly alleviated various pathological alterations.


CONCLUSIONS
The results suggest that: (1) a characteristic rat model of HPS can be non-invasively induced by multiple pathogenic factors including high fat diet, alcohol, cholesterol and CCl(4); (2) this model can be used for study of hepatopulmonary syndrome and is clinically relevant; and (3) intestinal endotoxemia (IETM) and its accompanying cytokines, such as TNF-alpha, exert a crucial role in the pathogenesis of HPS in this model.
Zhang
Hui-Ying
HY
Director of Institute of Hepatology, Shanxi Medical University, 86 Xin-jian Nan Road, Taiyuan 030001, Shanxi Province, China.
Han
De-Wu
DW
Zhao
Zhong-Fu
ZF
Liu
Ming-She
MS
Wu
Yan-Jun
YJ
Chen
Xian-Ming
XM
Ji
Cheng
C
D000818:Animals; D018988:Bacterial Translocation; D004195:Disease Models, Animal; D019446:Endotoxemia / Q000150:complications*; D020065:Hepatopulmonary Syndrome / Q000209:etiology*; D008070:Lipopolysaccharides / Q000633:toxicity; D008106:Liver Cirrhosis, Experimental / Q000150:complications*; D008168:Lung / Q000473:pathology; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D014409:Tumor Necrosis Factor-alpha / Q000097:blood
D008070:Lipopolysaccharides; D014409:Tumor Necrosis Factor-alpha